Advertisement
Canada markets close in 2 hours 4 minutes
  • S&P/TSX

    21,839.61
    +111.06 (+0.51%)
     
  • S&P 500

    5,053.87
    +35.48 (+0.71%)
     
  • DOW

    38,161.35
    +258.06 (+0.68%)
     
  • CAD/USD

    0.7308
    +0.0027 (+0.37%)
     
  • CRUDE OIL

    79.01
    +0.01 (+0.01%)
     
  • Bitcoin CAD

    80,961.04
    +2,222.20 (+2.82%)
     
  • CMC Crypto 200

    1,272.98
    +2.24 (+0.18%)
     
  • GOLD FUTURES

    2,314.80
    +3.80 (+0.16%)
     
  • RUSSELL 2000

    2,007.29
    +27.06 (+1.37%)
     
  • 10-Yr Bond

    4.5810
    -0.0140 (-0.30%)
     
  • NASDAQ

    15,790.50
    +185.01 (+1.19%)
     
  • VOLATILITY

    14.87
    -0.52 (-3.38%)
     
  • FTSE

    8,172.15
    +50.91 (+0.63%)
     
  • NIKKEI 225

    38,236.07
    -37.98 (-0.10%)
     
  • CAD/EUR

    0.6814
    +0.0021 (+0.31%)
     

Stericycle Insider Ups Holding By 41% During Year

Viewing insider transactions for Stericycle, Inc.'s (NASDAQ:SRCL ) over the last year, we see that insiders were net buyers. This means that a larger number of shares were purchased by insiders in relation to shares sold.

Although we don't think shareholders should simply follow insider transactions, logic dictates you should pay some attention to whether insiders are buying or selling shares.

See our latest analysis for Stericycle

The Last 12 Months Of Insider Transactions At Stericycle

In the last twelve months, the biggest single purchase by an insider was when Executive VP & Chief People Officer Joseph Reuter bought US$309k worth of shares at a price of US$44.09 per share. That means that an insider was happy to buy shares at around the current price of US$48.87. While their view may have changed since the purchase was made, this does at least suggest they have had confidence in the company's future. While we always like to see insider buying, it's less meaningful if the purchases were made at much lower prices, as the opportunity they saw may have passed. Happily, the Stericycle insider decided to buy shares at close to current prices. The only individual insider to buy over the last year was Joseph Reuter.

ADVERTISEMENT

You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. By clicking on the graph below, you can see the precise details of each insider transaction!

insider-trading-volume
insider-trading-volume

There are plenty of other companies that have insiders buying up shares. You probably do not want to miss this free list of growing companies that insiders are buying.

Does Stericycle Boast High Insider Ownership?

I like to look at how many shares insiders own in a company, to help inform my view of how aligned they are with insiders. Usually, the higher the insider ownership, the more likely it is that insiders will be incentivised to build the company for the long term. It appears that Stericycle insiders own 0.5% of the company, worth about US$23m. While this is a strong but not outstanding level of insider ownership, it's enough to indicate some alignment between management and smaller shareholders.

So What Does This Data Suggest About Stericycle Insiders?

It doesn't really mean much that no insider has traded Stericycle shares in the last quarter. On a brighter note, the transactions over the last year are encouraging. Insiders own shares in Stericycle and we see no evidence to suggest they are worried about the future. In addition to knowing about insider transactions going on, it's beneficial to identify the risks facing Stericycle. Every company has risks, and we've spotted 1 warning sign for Stericycle you should know about.

Of course Stericycle may not be the best stock to buy. So you may wish to see this free collection of high quality companies.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.